Testing effectiveness (Phase 2)WithdrawnNCT04996056
What this trial is testing
An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects
Who this might be right for
Cocaine Intoxication
Tonix Pharmaceuticals, Inc.